Disease areas

We concentrate on key areas of medicine where we can create the greatest impact. Explore the disease areas where we are committed to supporting you.

Disease areas

Built for the patient journey

Patients have always been at the heart of everything we do. With patients increasingly involved in determining their healthcare options, we remain committed to Patient Engagement and are partnering with patients and caregivers to learn more about their experiences. These precious insights help us ensure we are developing the right medicines, improving clinical trials, and creating educational materials that are accessible and easy to understand.

At J&J, we believe that patients and their caregivers hold key information on how to improve healthcare processes and systems. We partner directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. We are committed to working toward patient-inspired innovation, including:

Clinical trials

Listening to and implementing patient perspectives into clinical trial procedures.

Early drug development

Incorporating patient-reported outcomes in medicine labels.

Administrating medicine

Modifying product design for administering medicine based on patient input.

Check our disease areas

Cancer
Blood cancer
Mental health
Rheumatology
Psoriatic disease
Gastroenterology
Autoimmune diseases
Human Immunodeficiency Virus (HIV)
AL Amyloidosis
Pulmonary Arterial Hypertension (PAH)

References

Myeloma UK. Myeloma: an introduction. Available at: https://www.myeloma.org.uk/wp-content/uploads/2018/03/Myeloma-UK-Myeloma-An-Introduction-1.pdf Last accessed: February 2025.
International Myeloma Foundation. Concise review of the disease and treatment options. 2017 edition. Available at: https://imf-d8-prod.s3.us-west-1.wasabisys.com/resource/ConciseReview.pdf Last accessed: February 2025.
Memorial Sloan Kettering Cancer Center. Multiple Myeloma Symptoms. https://www.mskcc.org/cancer-care/types/multiple-myeloma/multiple-myeloma-symptoms Last accessed: February 2025.
Gavriatopoulou M, et al. Metabolic Disorders in Multiple Myeloma. Int J Mol Sci. 2021;22(21):11430.
American Cancer Society. Multiple myeloma: causes, risk factors, and prevention. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8739.00.pdf. Last accessed: February 2025.
Myeloma Patients Europe. Multiple Myeloma – A Patients’ Guide. Available at: www.mpeurope.org/files/Patients-guide-mpe-web-version-V2.pdf. Last accessed: February 2025.
International Myeloma Foundation. Understanding MGUS and Smoldering Multiple Myeloma, and Active Myeloma. Available at: https://www.myeloma.org/what-are-mgus-smm-mm Last accessed: February 2025.
International Myeloma Foundation. Concise review of the disease and treatment options. 2017 edition. Available at: https://imf-d8-prod.s3.us-west-1.wasabisys.com/resource/ConciseReview.pdf Last accessed: February 2025.
Moreau P, et al. Ann Oncol. 2017;28 (Suppl 4):iv52-iv61
WebMD. Smoldering Multiple Myeloma. Available at: https://www.webmd.com/cancer/multiple-myeloma/smoldering-multiple-myeloma. Last accessed: February 2025.
American Cancer Society. About multiple myeloma. Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/what-is-multiple-myeloma.html. Last accessed: February 2025.
Hughes, D, Yong, K, Ramasamy, K et al. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 2024: 1193-2016.
NHS Inform. Multiple Myeloma – About multiple myeloma. Available at: https://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/multiple-myeloma
Bahlis NJ, Lazarus HM. Multiple myeloma-associated AL amyloidosis. Bone Marrow Transplantation. 2006;38;7-15.
Vaxman I, Gatt ME. Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question. Br J Haematol. 2024; 204(4): 1141–1142.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson